Return to article list



NEUROSCOUT™ 14 Steerable Guidewire Offers Physicians Precision in Placing Microcatheters for Neurovascular Access
PHILADELPHIA – MAY 3, 2010 – Codman & Shurtleff, Inc. (Codman), a global neuroscience and neurovascular company, today announced the launch of NEUROSCOUT™ 14 Steerable Guidewire, a newly developed steerable guidewire that facilitates the placement of diagnostic or therapeutic catheters within the neurovasculature.
            Codman made the announcement at the American Association of Neurological Surgeons (AANS) annual meeting, where it will showcase the new guidewire technology alongside its line of coils, intra-cranial stents, catheters and other central nervous system (CNS) devices and solutions including programmable shunt systems, trauma monitoring devices and drug pumps.
Neurovascular guidewires are placed inside catheters, flexible tubes that are used to carry coils or stents to treat conditions such as aneurysms and cerebral arteriovenous malformations, the two leading causes of hemorrhagic stroke.  According to the American Heart Association, stroke is the third most common cause of death in the U.S., accounting for one in every 18 deaths in 2006.

“The control and versatility of the NEUROSCOUT 14 Guidewire is excellent and navigates delicate anatomy with ease,” said Adnan H. Siddiqui, MD, PhD and Assistant Professor of Neurosurgery & Radiology at SUNY’s University of Buffalo in Buffalo, NY. “The combination of features represents an advance in guidewire technology.”
The NEUROSCOUT 14 Guidewire features a uniquely designed, flattened distal segment with a stainless steel core that retains its shape over time, enabling easy vessel access and re-access. A technologically enhanced surface with a highly lubricous surface coating reduces frictional forces with compatible devices and a 10cm platinum distal coil section provides increased visualization under fluoroscopy.2 Exclusive core wire technology is designed to deliver precise torque transmission, excellent tip control and pushability. The NEUROSCOUT 14 guidewire measures .014 inches in diameter and is available in standard and soft versions with usable lengths of 205 and 300 cm.   
 “The launch of the NEUROSCOUT 14 Guidewire is the first product launch for Codman Neurovascular since the integration of the Cordis Neurovascular unit into our company last year.  This marks the beginning of what will be a steady stream of new products and solutions in the neurovascular area that will fill unmet clinical needs and help neurosurgeons and interventionalists improve patient outcomes,” said P. Laxminarain, Worldwide President of Codman. 
About Codman & Shurtleff, Inc.
Codman is a global neuroscience and neurovascular company that develops and markets a wide range of products and solutions for the diagnosis and treatment of neurological disorders including chronic pain management, adult and pediatric hydrocephalus, neuro critical care, aneurysm and stroke prevention and management. Codman is part of the DePuy Family of Companies. The DePuy Family of Companies has a rich heritage of pioneering a broad range of products and solutions across the continuum of orthopaedic and neurological care.  These companies are unified under one vision – Never Stop Moving™ – to express their commitment to bring meaningful innovation, shared knowledge and quality care to patients throughout the world. Visit for more information.
1 American Heart Association. Heart Disease and Stroke Statistics – 2009 Update. Circulation. 2009; 119:ee21-e181. Available from .
2 As compared to competitive neurovascular guidewires.
Filed under: Tagged: